Ryman Healthcare Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ryman Healthcare Limited generated cash of $658,482,000, which is more than the previous year. Cash used in financing activities reached the amount of $197,501,000 last year. Net change in cash is therefore $13,930,000.
Cash Flow
| 2015 | 234.00M | -300.38M | 65.03M |
|---|---|---|---|
| 2016 | 312.46M | -369.43M | 55.49M |
| 2017 | 322.79M | -525.75M | 203.91M |
| 2018 | 349.25M | -478.89M | 129.63M |
| 2019 | 401.42M | -554.67M | 153.25M |
| 2020 | 414.88M | -678.57M | 298.06M |
| 2021 | 375.94M | -807.29M | 417.15M |
| 2022 | 535.97M | -737.30M | 209.47M |
| 2023 | 542.76M | -931.79M | 388.60M |
| 2024 | 658.48M | -842.05M | 197.50M |
RYHTY Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 27.87M | 28.30M | 20.17M | 34.37M | 0 | 0 | 0 | -961K | 409K | 1.75M |
Operating activities | ||||||||||
Net income | 0 | 257.83M | 692.87M | 423.06M | 264.70M | 325.98M | 388.21M | 356.69M | 305.42M | 241.91M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 46.59M | 35.69M | 32.36M | 28.61M | 20.52M | 19.26M | 14.93M | 12.65M | 10.76M |
Stock-based compensation expense | 2.93M | 0 | 0 | 0 | 0 | 0 | 100.22M | 30.50M | 18.46M | 0 |
| Deferred income tax benefit | 2.93M | 0 | 0 | 0 | 0 | 0 | 100.22M | 30.50M | 18.46M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 41.08M | -138.40M | -202.84M | -151.68M | -145.17M | 12.66M | -100.86M | -36.79M | -22.37M | -90.90M |
Inventories | 12.23M | 11.63M | 390K | -26.73M | 0 | -382.44M | -439.87M | -348.93M | -326.12M | 0 |
Accounts payable | -2.65M | 41.11M | 9.17M | 4.84M | 5.50M | 2.16M | -2.40M | 13.1M | -7.16M | 0 |
Cash generated by operating activities | 658.48M | 542.76M | 535.97M | 375.94M | 414.88M | 401.42M | 349.25M | 322.79M | 312.46M | 234.00M |
Investing activities | ||||||||||
Purchases Of Investments | -582.55M | -608.78M | -434.39M | -577.50M | -401.61M | -364.18M | -269.93M | -314.92M | -224.65M | -166.32M |
Investments In Property Plant And Equipment | -264.42M | -324.20M | -298.63M | -228.87M | -274.88M | -181.25M | -201.59M | -209.35M | -144.92M | -133.34M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -842.05M | -931.79M | -737.30M | -807.29M | -678.57M | -554.67M | -478.89M | -525.75M | -369.43M | -300.38M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 878.68M | 0 | -2.47M | -416.97M | 0 | -223.63M | 0 | -128.49M | 0 |
Payments for dividends | 0 | -68.08M | -112M | -107.5M | -117M | -108.5M | -94M | -85M | -73M | -62.5M |
Repurchases of common stock | -352K | 0 | -2.78M | -3.02M | -4.89M | -4.96M | -1.95M | -4.64M | -4.54M | -2.46M |
Repayments of term debt | 201.21M | 436.72M | 326.91M | -36.71M | -421.87M | 266.71M | -225.59M | 293.55M | -133.04M | 129.99M |
Cash used in financing activities | 197.50M | 388.60M | 209.47M | 417.15M | 298.06M | 153.25M | 129.63M | 203.91M | 55.49M | 65.03M |
Net Change In Cash | 13.93M | -430K | 8.13M | -14.20M | 34.37M | 0 | 0 | 961K | -1.37M | -1.34M |
Cash at end of period | 41.80M | 27.87M | 28.30M | 20.17M | 34.37M | 0 | 0 | 0 | -961K | 409K |